Newrology
A fresh approach to helping patients thrive
A pipeline for patient-kind
Harmony Biosciences’ patient-focused drug development model uses patient insights to inform clinical research programs.
The Struggle to Stay Awake: Recognizing Pediatric Narcolepsy
In this television broadcast about pediatric narcolepsy from The Lifetime Network, sponsored by Harmony Biosciences, learn about this often underdiagnosed and misdiagnosed disorder and meet a mother who trusted her instincts to help her son.
Nov 4, 2026
Harmony Biosciences Reports Q3 Financial Results on Track to Achieve More Than $1 Billion WAKIX Net Revenue and Announces Strong Multiple-Ascending Dose Data for Its Orexin Agonist BP-205, Supporting Potential Best-in-Class Profile
Oct 20, 2026
Harmony Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
Oct 12, 2026
Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth
available now
Discover our Products
From discovery to delivery, Harmony Biosciences is committed to getting medicines to the people who need them most.
The Harmony Team
Meet our leaders who share an uncommon commitment for addressing patients’ unmet medical needs.
Senior Leadership